Effect of Adenoviral Vector Infection on Cell Proliferation in Cultured Primary Human Airway Epithelial Cells
- 1 August 1995
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 6 (8) , 1045-1053
- https://doi.org/10.1089/hum.1995.6.8-1045
Abstract
Although recombinant adenoviruses are used as vectors for delivering therapeutic genes to the airways of cystic fibrosis (CF) patients, the effects of these vectors on the kinetics of airway epithelial cell growth have not been investigated. We tested whether E1, E3-deleted Ad vectors (Ad5-CMV-lacZ) affect the kinetics of cell proliferation of human airway epithelial cells in primary culture. There was a dose-dependent relationship between the vector multiplicity of infection (moi) and the efficiency of Ad-mediated lacZ gene transfer. Growth curves of cells exposed to vector were shifted to the right as compared to vehicle in a dose-dependent manner. The vector-induced slowing of cell proliferation resulted from both (i) increased apoptotic cell death and (ii) lower recruitment into S phase. UV inactivation of the vector genes abolished the effects on cell proliferation. These data demonstrate that as the moi of vectors is increased to achieve effective gene transfer, apoptosis and slowing of the cell cycle of infected cells increases concomitantly. The identification and inactivation of these vector effects on human airway cells may be important for reducing the toxicity of adenovirus vectors for gene therapy of CF airways.Keywords
This publication has 31 references indexed in Scilit:
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Gene Therapy for Cystic Fibrosis Utilizing a Replication Deficient Recombinant Adenovirus Vector to Deliver the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Airways. A Phase I Study. Children's Hospital Medical Center, Cincinnati, OhioHuman Gene Therapy, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Evaluation of the Efficacy and Safety ofIn Vitro, Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNAHuman Gene Therapy, 1994
- Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaHuman Gene Therapy, 1994
- Gene Therapy of Cystic Fibrosis Lung Disease Using E1 Deleted Adenoviruses: A Phase I Trial. University of Michigan, Ann Arbor, Michigan and University of Pennsylvania, Philadelphia, PennsylvaniaHuman Gene Therapy, 1994
- Surfactant Protein A-Directed Toxin Gene Kills Lung Cancer Cells In VitroHuman Gene Therapy, 1994
- Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic FibrosisHuman Gene Therapy, 1993
- High-Efficiency Gene Transfer to Primary Monkey Airway Epithelial Cells with Retrovirus Vectors Using the Gibbon Ape Leukemia Virus ReceptorHuman Gene Therapy, 1993
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980